Why the study?
Broader clinical application requires CXCR4-directed radiotracers labeled with isotopes suitable for SPECT to visualize CXCR4-positive immune cells after acute myocardial infarction.
Does [99mTc]-PentixaTec SPECT/CT enable detection of CXCR4 expression after acute myocardial infarction in humans?
Does [99mTc]-PentixaTec SPECT/CT enable detection of CXCR4 expression after acute myocardial infarction in humans?
[99mTc]-PentixaTec SPECT/CT is feasible for in vivo imaging of inflammation-related CXCR4 expression in the myocardium after acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
Feasible for post-MI CXCR4 SPECT in this series; leaves open clinical utility pending prospective validation.
BACKGROUND: Accumulation of CXCR4 (C-X-C motif chemokine receptor 4)–positive immune cells after acute myocardial infarction (AMI) can be visualized by positron emission tomography. For a broader clinical application, there is a need for CXCR4-directed radiotracers labeled with isotopes that can be used with single-photon emission computed tomography (SPECT). We report on the detection of CXCR4 expression after AMI in humans using the novel tracer [ 99m Tc]-PentixaTec. METHODS: In this retrospective analysis, 9 patients with AMI after mechanical revascularization underwent myocardial inflammation imaging with [ 99m Tc]-PentixaTec SPECT/computed tomography and rest perfusion SPECT imaging. Tracer uptake in the infarcted area, spleen, bone marrow, and blood pool were used for semiquantitative analysis and calculation of signal-to-background ratios. The extent and intensity of SPECT-derived inflammatory changes were compared with serological markers and perfusion defects. RESULTS: CXCR4-directed SPECT was positive in all patients. Increased CXCR4 expression was only detected in areas with diminished perfusion corresponding to the affected vessel in coronary angiography, with a signal-to-background ratio (infarcted area-to-blood pool) of 2.36±0.74. Uptake in bone marrow and spleen showed a significant correlation with CXCR4 expression in the infarcted areas (r=0.73 and P =0.03 for spleen and r=0.81 and P =0.008 for bone marrow, respectively). The extent and intensity of SPECT-derived inflammatory changes showed no significant association with serum troponin, CK (creatine kinase), leukocyte, or CRP (C-reactive protein) levels. CONCLUSIONS: This is the first report of in vivo CXCR4 imaging after AMI using a 99m Tc-labeled tracer. Increased CXCR4 expression was observed locally in the infarcted region and was related to a systemic inflammatory response in the reticuloendothelial system. This proof-of-concept investigation demonstrates the general feasibility of evaluating the inflammation-related CXCR4 expression in the myocardium after AMI using conventional scintigraphy or SPECT and might, thus, broaden its worldwide application in clinical practice.
No takes yet. Share an insight, caveat, or question.
Liebich et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: